Miller DH - Search Results

1

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F. Montalban X, et al. Among authors: miller dh. Eur J Neurol. 2018 Feb;25(2):215-237. doi: 10.1111/ene.13536. Epub 2018 Jan 19. Eur J Neurol. 2018. PMID: 29352526 Free article.

2

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Miller DH, et al. J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):683-8. doi: 10.1136/jnnp.54.8.683. J Neurol Neurosurg Psychiatry. 1991. PMID: 1940938 Free PMC article.

3

Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis.

Miller DH, Thompson AJ. Miller DH, et al. Philos Trans R Soc Lond B Biol Sci. 1999 Oct 29;354(1390):1687-95. doi: 10.1098/rstb.1999.0512. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10603620 Free PMC article. Review.

4

T1 hypointensity of the spinal cord in multiple sclerosis.

Losseff NA, Wang L, Miller DH, Thompson AJ. Losseff NA, et al. Among authors: miller dh. J Neurol. 2001 Jun;248(6):517-21. doi: 10.1007/s004150170163. J Neurol. 2001. PMID: 11499644

5

Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis.

Miller DH, Thompson AJ, Filippi M. Miller DH, et al. J Neurol. 2003 Dec;250(12):1407-19. doi: 10.1007/s00415-003-0243-9. J Neurol. 2003. PMID: 14673572 Review.

6

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial.

Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Hemmer B, Fox EJ, Barkhof F, Schippling S, Schulze A, Pleimes D, Pohl C, Sandbrink R, Suarez G, Wicklein EM; BENEFIT Study Group. Kappos L, et al. Neurology. 2016 Sep 6;87(10):978-87. doi: 10.1212/WNL.0000000000003078. Epub 2016 Aug 10. Neurology. 2016. PMID: 27511182 Free PMC article. Clinical Trial.

7

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study.

Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, Zhao GJ, Wiles CM, McDonald WI, Miller DH. Filippi M, et al. Among authors: miller dh. Neurology. 1995 Feb;45(2):255-60. doi: 10.1212/wnl.45.2.255. Neurology. 1995. PMID: 7854522 Clinical Trial.

8

Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta.

McDonald WI, Miller DH, Thompson AJ. McDonald WI, et al. Among authors: miller dh. Ann Neurol. 1994 Jul;36(1):14-8. doi: 10.1002/ana.410360106. Ann Neurol. 1994. PMID: 8024255 Review. No abstract available.

9

Benign form of multiple sclerosis: MRI evidence for less frequent and less inflammatory disease activity.

Kidd D, Thompson AJ, Kendall BE, Miller DH, McDonald WI. Kidd D, et al. Among authors: miller dh. J Neurol Neurosurg Psychiatry. 1994 Sep;57(9):1070-2. doi: 10.1136/jnnp.57.9.1070. J Neurol Neurosurg Psychiatry. 1994. PMID: 8089671 Free PMC article.

10

Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study.

Filippi M, Barker GJ, Horsfield MA, Sacares PR, MacManus DG, Thompson AJ, Tofts PS, McDonald WI, Miller DH. Filippi M, et al. Among authors: miller dh. J Neurol. 1994 Feb;241(4):246-51. doi: 10.1007/BF00863776. J Neurol. 1994. PMID: 8195825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,170 results

Search Page